Latest & greatest articles for dementia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on dementia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on dementia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for dementia

81. Living condition, weight loss and cognitive decline among people with dementia Full Text available with Trip Pro

Living condition, weight loss and cognitive decline among people with dementia The aim of this study was to investigate cognitive performance and BMI of patients with dementia living in their own homes with family members, nursing homes and alone.A prospective observational cohort study with a quantitative design.Mini-mental state examination (MMSE) scores and BMI were examined with a sample of Slovak patients (N = 428). Patients were followed up 12 months later after the first (...) examination.Cognitive decline was significantly faster for patients living in nursing homes and for solitary patients. BMI consistently decreased in the follow-up examination and this drop was stronger in patients living alone and in nursing homes. Patients with VaD manifested a stronger BMI decline as compared with AD patients. This study suggests that impoverished conditions such as nursing homes or social isolation of solitary people contribute to stronger progress in dementia. Healthcare professionals need

2018 Nursing open

82. Astrocyte dysfunction following molybdenum-associated purine loading could initiate Parkinson’s disease with dementia Full Text available with Trip Pro

Astrocyte dysfunction following molybdenum-associated purine loading could initiate Parkinson’s disease with dementia Sporadic or idiopathic Parkinson's disease is a movement disorder with a worldwide distribution, a long pre-clinical latent period and a frequent association with dementia. The combination of molybdenum deficiency and purine ingestion could explain the movement disorder, the distribution, the latent period and the dementia association. Recent studies in sheep have shown (...) receptors in the nigro-striatum. This could result in Parkinson's disease. Guanosine ingestion in molybdenum-deficient humans will lead to guanosine loading and potentially a disturbance to the guanosine receptors in the hippocampus, amygdala and ventral striatum. This could result in dementia. The molybdenum content of the average daily diet in the United States is 0.07 ppm and in the United Kingdom 0.04 ppm. Central nervous system disease occurs in sheep at <0.04 ppm. Consistent with the role proposed

2018 NPJ Parkinson's disease

83. Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a primary care setting. Full Text available with Trip Pro

Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a primary care setting. Alzheimer's disease and other forms of dementia are becoming increasingly common with the aging of most populations. The majority of individuals with dementia will first present for care and assessment in primary care settings. There is a need for brief dementia screening instruments that can accurately diagnose dementia in primary care settings. The Mini-Cog is a brief, cognitive (...) screening test that is frequently used to evaluate cognition in older adults in various settings.To determine the diagnostic accuracy of the Mini-Cog for diagnosing Alzheimer's disease dementia and related dementias in a primary care setting.We searched the Cochrane Dementia and Cognitive Improvement Register of Diagnostic Test Accuracy Studies, MEDLINE, Embase and four other databases, initially to September 2012. Since then, four updates to the search were performed using the same search methods

2018 Cochrane

84. ACHIEVING A PEACEFUL DEATH: What We've Learned in 30 Years, Including Dementia

ACHIEVING A PEACEFUL DEATH: What We've Learned in 30 Years, Including Dementia I not a bot. Resume. Are you not a robot? Click on the button to continue: I not a bot. Resume.

2018 MedicalVideos

85. Diagnosis of dementia in the elderly with PTSD

Diagnosis of dementia in the elderly with PTSD Diagnosis of dementia in the elderly with PTSD We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Swedish Agency for Health Technology Assessment and Assessment of Social Services Diagnosis of dementia in the elderly with PTSD Share: Reading time less than 1 minute Some of the symptoms of posttraumatic stress disorder (PTSD) remind of the symptoms of early development of dementia (...) . This can make it difficult with an assessment tool to clearly see if a person diagnosed with PTSD has started to develop dementia. Question Is there scientific evidence for any assessment tool that can identify development of dementia in the elderly with PTSD? SBU Enquiry Service consists of systematic literature searches to highlight studies that can address questions received by the SBU Enquiry Service from Swedish healthcare or social service providers. Relevant references are compiled by an SBU

2018 Swedish Council on Technology Assessement

86. Effects of Cognitive Training on Cognition and Quality of Life of Older Persons with Dementia (Abstract)

Effects of Cognitive Training on Cognition and Quality of Life of Older Persons with Dementia To evaluate the effect of cognitive training on cognition and health-related quality of life (HRQoL) in community-dwelling persons with dementia.Single-blind randomized controlled trial with 3- and 9-month follow-up.Adult day care centers in Helsinki, Finland.Older individuals with mild to moderate dementia living at home and attending adult day care twice a week (N = 147; mean age 83, 72% female, 63 (...) % at mild stage of dementia).A systematic 12-week training program focused on subskills of executive function: attention, working memory, cognitive flexibility, and planning. The intervention group (n = 76) underwent cognitive training twice a week for 45 minutes, and the control group (n = 71) attended day care as usual.Primary outcomes were the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) for global cognition and the 15-dimensional instrument (15D) for HRQoL. The outcomes were

2018 EvidenceUpdates

87. What is desirable care in the opinion of formal and informal caregivers in nursing‐home care for patients with dementia? Full Text available with Trip Pro

What is desirable care in the opinion of formal and informal caregivers in nursing‐home care for patients with dementia? To examine care characteristics related to desirable care as reported by formal and informal caregivers in Dutch Psycho-geriatric nursing homes for patients with dementia.Qualitative exploratory study.The sample consisted of four nursing homes. In each home, semi-structured interviews were conducted with a manager, a quality advisor or head nurse, a daily care supervisor

2018 Nursing open

88. Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease. Full Text available with Trip Pro

Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease. Alzheimer's disease is characterized by amyloid-beta (Aβ) plaques and neurofibrillary tangles. The humanized monoclonal antibody solanezumab was designed to increase the clearance from the brain of soluble Aβ, peptides that may lead to toxic effects in the synapses and precede the deposition of fibrillary amyloid.We conducted a double-blind, placebo-controlled, phase 3 trial involving patients with mild dementia due

2018 NEJM Controlled trial quality: predicted high

89. Advancing Care for Family Caregivers of persons with dementia through caregiver and community partnerships Full Text available with Trip Pro

Advancing Care for Family Caregivers of persons with dementia through caregiver and community partnerships There are currently 15 million Americans who provide over 80% of the care required by their family members with Alzheimer's disease and other dementias. Yet care for caregivers continues to be fragmented and few evidence-based interventions have been translated into routine clinical care and therefore remain inaccessible to most family caregivers. To address this gap, the Caring

2018 Research involvement and engagement

90. Cannabinoids for Behavioural Symptoms in Adults with Dementia: A Review of Clinical Effectiveness and Guidelines

Cannabinoids for Behavioural Symptoms in Adults with Dementia: A Review of Clinical Effectiveness and Guidelines Cannabinoids for Behavioural Symptoms in Adults with Dementia: A Review of Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Cannabinoids for Behavioural Symptoms in Adults with Dementia: A Review of Clinical Effectiveness and Guidelines Cannabinoids for Behavioural Symptoms in Adults with Dementia: A Review of Clinical Effectiveness and Guidelines (...) Published on: January 5, 2018 Project Number: RC0952-000 Product Line: Research Type: Drug Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical effectiveness of cannabinoids for the treatment of behavioural symptoms in adults with dementia? What are the evidence-based guidelines regarding the use of cannabinoids for the treatment of behavioural symptoms in adults with dementia? Key Message A total of four publications met the inclusion criteria: two systematic

2018 Canadian Agency for Drugs and Technologies in Health - Rapid Review

91. Cannabinoids for Behavioural Symptoms in Adults with Dementia: A Review of Clinical Effectiveness and Guidelines

Cannabinoids for Behavioural Symptoms in Adults with Dementia: A Review of Clinical Effectiveness and Guidelines Cannabinoids for Behavioural Symptoms in Adults with Dementia: A Review of Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Cannabinoids for Behavioural Symptoms in Adults with Dementia: A Review of Clinical Effectiveness and Guidelines Cannabinoids for Behavioural Symptoms in Adults with Dementia: A Review of Clinical Effectiveness and Guidelines (...) Published on: January 5, 2018 Project Number: RC0952-000 Product Line: Research Type: Drug Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical effectiveness of cannabinoids for the treatment of behavioural symptoms in adults with dementia? What are the evidence-based guidelines regarding the use of cannabinoids for the treatment of behavioural symptoms in adults with dementia? Key Message A total of four publications met the inclusion criteria: two systematic

2018 Canadian Agency for Drugs and Technologies in Health - Rapid Review

92. Challenges in end-of-life dementia care

Challenges in end-of-life dementia care Challenges in end-of-life dementia care | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword (...) Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Challenges in end-of-life dementia care Article Text Clinical review Challenges in end-of-life dementia care Anne A Fetherston , Grace Rowley , Charlotte L Allan , Statistics from Altmetric.com Footnotes Funding The authors have not declared a specific grant for this research from any funding agency

2018 Evidence-Based Mental Health

93. Risk of suicidal thinking in caregivers of people with dementia should be assessed and monitored by health professionals Full Text available with Trip Pro

Risk of suicidal thinking in caregivers of people with dementia should be assessed and monitored by health professionals Risk of suicidal thinking in caregivers of people with dementia should be assessed and monitored by health professionals | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Risk of suicidal thinking in caregivers of people with dementia should be assessed and monitored by health professionals Article Text Commentary Mental

2018 Evidence-Based Nursing

94. Care of the older person: Antihypertensive medications may reduce the risk of dementia in older African–Americans with hypertension Full Text available with Trip Pro

Care of the older person: Antihypertensive medications may reduce the risk of dementia in older African–Americans with hypertension Antihypertensive medications may reduce the risk of dementia in older African–Americans with hypertension | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Antihypertensive medications may reduce the risk of dementia in older African–Americans with hypertension Article Text Commentary Care of the older person

2018 Evidence-Based Nursing

95. Dementia Villages

Dementia Villages Dementia Villages | CADTH.ca Find the information you need Dementia Villages Dementia Villages Last updated: October 11, 2019 Project Number: EH0071-000 Product Line: Result type: Report Expected Completion Date: October 16, 2019 As the population ages, decision-makers are faced with different choices of care models for people diagnosed with dementia. Recent media reports have focused on dementia villages, first developed at de Hogeweyk in the Netherlands. This Horizon (...) Scanning bulletin will present a narrative review of the literature describing elements of care, as well as evidence and issues concerning dementia villages and similar models or components of care. Stakeholder perspectives and an analysis of policy issues will also be incorporated. Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies and expected completion

2018 CADTH - Issues in Emerging Health Technologies

96. Sensory Rooms for Patients with Dementia in Long-Term Care: Clinical and Cost-Effectiveness, and Guidelines

Sensory Rooms for Patients with Dementia in Long-Term Care: Clinical and Cost-Effectiveness, and Guidelines Sensory Rooms for Patients with Dementia in Long-Term Care: Clinical and Cost-Effectiveness, and Guidelines | CADTH.ca Find the information you need Sensory Rooms for Patients with Dementia in Long-Term Care: Clinical and Cost-Effectiveness, and Guidelines Sensory Rooms for Patients with Dementia in Long-Term Care: Clinical and Cost-Effectiveness, and Guidelines Last updated: July 6, 2018 (...) Project Number: RC0999-000 Product Line: Research Type: Devices and Systems Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical effectiveness of sensory rooms for patients with dementia in long-term care? What is the cost-effectiveness of sensory rooms for patients with dementia in long-term care? What are the evidence-based guidelines regarding the use of sensory rooms for patients with dementia in long-term care? Key Message Based on the evidence identified

2018 Canadian Agency for Drugs and Technologies in Health - Rapid Review

97. Does Structured Exercise Improve Cognitive Impairment in People with Mild to Moderate Dementia? A Cost-Effectiveness Analysis from a Confirmatory Randomised Controlled Trial: The Dementia and Physical Activity (DAPA) Trial. Full Text available with Trip Pro

Does Structured Exercise Improve Cognitive Impairment in People with Mild to Moderate Dementia? A Cost-Effectiveness Analysis from a Confirmatory Randomised Controlled Trial: The Dementia and Physical Activity (DAPA) Trial. Previous studies suggest that physical exercise could slow dementia progression. However, evidence for the cost effectiveness of structured exercise is conflicting and based on small trials.The objective of this study was to compare the cost effectiveness of a tailored (...) on the clinical results of the trial, which showed that the structured exercise programme evaluated does not slow cognitive impairment in people with mild to moderate dementia, this economic evaluation shows that the programme is not cost effective.

2018 PharmacoEconomics - open Controlled trial quality: predicted high

98. User experience and clinical effectiveness with two wearable global positioning system devices in home dementia care. Full Text available with Trip Pro

User experience and clinical effectiveness with two wearable global positioning system devices in home dementia care. The user experience and clinical effectiveness with wearable global positioning system (GPS) devices for persons with dementia (PwDs) and caregivers (CGs) remain unclear although many are available.Using a crossover design, 20 dyads tested two similar commercial GPS watches (products A and B) at home for 4 weeks each. Usability, product functions, design features and product

2018 Alzheimer's & dementia (New York, N. Y.) Controlled trial quality: uncertain

99. Antipsychotic medicines for treating agitation, aggression and distress in people living with dementia

Antipsychotic medicines for treating agitation, aggression and distress in people living with dementia Decision aid for Dementia: assessment, management and support for people living with dementia and their carers © NICE 2018. All rights reserved. Subject to Notice of rights. Last updated June 2018 Page 1 of 4 Decision aid Antipsychotic medicines for treating agitation, aggression and distress in people living with dementia Information to help people living with dementia, their family members (...) and carers and their healthcare professionals discuss the options What are the options? People living with dementia can sometimes become aggressive or very agitated. They might also hear voices or see things that are not really there (called hallucinations) or believe that something is real or true when it is not (called delusions). This can be very distressing for them and their carers, and the person may become violent. Several things should be tried first to help calm the person (for example music

2018 Health Information and Quality Authority

100. Enteral (tube) feeding for people living with severe dementia

Enteral (tube) feeding for people living with severe dementia Decision aid for Dementia: assessment, management and support for people living with dementia and their carers © NICE 2018. All rights reserved. Subject to Notice of rights. Last updated June 2018 Page 1 of 2 Decision aid Enteral (tube) feeding for people living with severe dementia Information to help people living with severe dementia, their family members and carers and their healthcare professionals discuss the options What (...) are the options? People living with severe dementia often develop problems with eating and drinking. They may have swallowing problems. If this happens food or saliva may go down their windpipe and cause an infection in their lungs (aspiration pneumonia). This can be serious or even fatal. They may also have a reduced appetite, and in their final weeks or days they may stop eating or drinking altogether. Enteral (tube) feeding usually involves either passing a tube through a person’s nose and down

2018 Health Information and Quality Authority